State of Alaska Department of Revenue’s Sage Therapeutics SAGE Stock Holding History

State of Alaska Department of Revenue’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,329	Closed	-$141K	–	1636
2021 Q4	$141K	Sell	3,329 -66	-2%	-$2.76K	﹤0.01%	1630
2021 Q3	$150K	Sell	3,395 -7,374	-68%	-$338K	﹤0.01%	1623
2021 Q2	$611K	Buy	10,769 +3,148	+41%	+$223K	0.01%	1350
2021 Q1	$570K	Buy	+7,621	New	+$625K	0.01%	1363
2019 Q3	–	Sell	-5,700	Closed	-$1.04M	–	1726
2019 Q2	$1.04M	Buy	5,700 +20	+0.4%	+$3.41K	0.02%	722
2019 Q1	$903K	Buy	5,680 +75	+1%	+$10.9K	0.02%	767
2018 Q4	$536K	Buy	5,605 +41	+0.7%	+$4.69K	0.01%	932
2018 Q3	$785K	Buy	5,564 +44	+0.8%	+$6.79K	0.01%	843
2018 Q2	$864K	Buy	+5,520	New	+$867K	0.02%	772

Other funds holding SAGE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State of Alaska Department of Revenue's SAGE Position: Q1 2022 in Review

State of Alaska Department of Revenue sold out of Sage Therapeutics (SAGE) in Q1 2022, closing a stake of 3,329 shares — an estimated $141K sold.

State of Alaska Department of Revenue first reported a position in SAGE in Q2 2018 and held it in 9 quarters. The position peaked at $1.04M in Q2 2019. 212 funds tracked by Wall St. Rank hold SAGE as of Q1 2022.

State of Alaska Department of Revenue reported no remaining Sage Therapeutics position as of Q1 2022 after selling out during the quarter.
State of Alaska Department of Revenue sold 3,329 Sage Therapeutics shares in Q1 2022, an estimated $141K.
State of Alaska Department of Revenue first reported a position in Sage Therapeutics in Q2 2018 and held it in 9 quarters.
State of Alaska Department of Revenue's Sage Therapeutics position peaked at $1.04M in Q2 2019.
212 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2022.

Based on State of Alaska Department of Revenue's 13F filing for Q1 2022, filed 14 Apr 2022.